Searched for
PFIZER STOCK PERFORMANCE
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20%Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan PharmaceuticalsPfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacita...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Kajaria Ceramics, 3 other stocks cross 100-Day SMAThe stock market witnessed a notable upswing on October 3 as several midcap stocks showcased their strength by crossing their 100-day Simpl...
- Ambuja Cements, Dabur India among 5 stocks that crossed 200-Day SMAThe stock market witnessed a noteworthy resurgence on October 3 as several major stocks made a remarkable move by crossing their 200-day Si...
- KPIT Technologies and 4 other midcap stocks surpass 100-day SMAOn September 26, several noteworthy midcap stocks demonstrated their resilience by surpassing their 100-day SMA.
- Adani Total Gas, TVS Motor among 9 stocks which crossed 50-day SMAAugust 18, 2023, marked a significant day for the stock market as several stocks surpassed their 50-day Simple Moving Averages (SMA). This ...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Market Movers: What drove investors to cement producers’ counters today?Cement sector was largely ignored by investors after the second wave buying rush because of the uneven demand environment as well as rising...
- Centrum maintains buy on Pfizer, target price Rs 5,000Shares of Pfizer closed at Rs 4,128, up 2.5%.
- Pfizer, Wyeth merger to add more value to stocksIndian units of global drug majors Pfizer and Wyeth have been star performers on Dalal Street, notching up gains of nearly 55% and 60%, res...
- Top three pharma MNCs Novartis, Pfizer and Abbott lose 10% in 2013Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.
- Pfizer: No immediate cure seen for short-term hiccupsPfizer India, the Indian arm of the US drug major Pfizer Inc, reported muted performance for the four months ended March 2011.
- Licensing income holds key to Biocon growthAssuming company's branded business continues its growth momentum, Biocon's performance in coming quarters remain dependent on the amount o...
- Pfizer CEO forced to retire in July to get $180m packagePfizer’s former chief executive, Henry A McKinnell, who was forced into an early retirement in part because of investor anger about his ric...
- Pfizer may cut jobs, rejig biz to tide over crisisPfizer will likely slash staff and accelerate merger and licencing deals as the pressure on it to improve its financial performance intensi...
Load More
